Drugs / ELV/COBI/FTC/TDF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01694420 | Sep 2012 → Apr 2016 | HIV infectious disease | Duke University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ELV/COBI/FTC/TDF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01694420 ↗ |
| Known as | STRIBILD | “FDC ELV/COBI/FTC/TDF \[Stribild\] in acute HIV infection” NCT01694420 ↗ |